Chemomab Therapeutics Ltd.
For the period ended Mar 20, 2026. Filed Mar 20, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Mar 20, 2026 · Filed Mar 20, 2026
Use the contents to explore the available documents and sections.
CMMB$1.32+5.6%Stored close · as of Nov 6, 2026
Contents
EXPLANATORY NOTE
Chemomab Therapeutics Ltd. (the “Company”) hereby furnishes the following documents:
| (i) | Notice and Proxy Statement with respect to the Company’s annual general meeting of the shareholders (the “Meeting”) to be held on April 28, 2026, describing the proposals to be voted upon at the meeting, the procedure for voting in person or by proxy at the meeting and various other details related to the meeting. |
| (ii) | Proxy Card whereby holders of American Depository Shares of the Company may vote at the Meeting without attending in person. |
This Form 6-K is incorporated by reference into the Company’s Registration Statements on Form F-3 (File No. 333-275002 and 333-281750) and Form S-8 (File No. 333-259489 and No. 333-266868).
- 2 -
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.